Efficacy and Safety of Direct-Acting Antivirals in Hepatitis C Virus-Infected Patients Taking Proton Pump Inhibitors

被引：0
|
作者：
Wijarnpreecha, Karn [1 ]
Chesdachai, Supavit [2 ]
Thongprayoon, Charat [1 ]
Jaruvongvanich, Veeravich [3 ]
Ungprasert, Patompong [4 ]
Cheungpasitporn, Wisit [4 ]
机构：
[1] Bassett Med Ctr, Internal Med, Cooperstown, NY USA
[2] Mahidol Univ, Ramathibodi Hosp, Fac Med, Med, Bangkok, Thailand
[3] Univ Hawaii, Internal Med, Honolulu, HI 96822 USA
[4] Mayo Clin, Med, Rochester, MN USA
来源：
HEPATOLOGY | 2017年 / 66卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1163
引用
收藏
页码：625A / 625A
页数：1
相关论文
共 50 条
  • [1] Direct-acting antivirals for hepatitis C virus-infected patients with hepatocellular carcinoma
    Tajiri, Kazuto
    Ito, Hiroyuki
    Kawai, Kengo
    Kashii, Yoshiro
    Hayashi, Yuka
    Murayama, Aiko
    Minemura, Masami
    Takahara, Terumi
    Shimizu, Yukihiro
    Yasuda, Ichiro
    WORLD JOURNAL OF HEPATOLOGY, 2022, 14 (06) : 1190 - 1199
  • [2] Direct-acting antivirals for hepatitis C virus-infected patients with hepatocellular carcinoma
    Kazuto Tajiri
    Hiroyuki Ito
    Kengo Kawai
    Yoshiro Kashii
    Yuka Hayashi
    Aiko Murayama
    Masami Minemura
    Terumi Takahara
    Yukihiro Shimizu
    Ichiro Yasuda
    World Journal of Hepatology, 2022, 14 (06) : 1190 - 1199
  • [3] EFFECTIVENESS AND SAFETY OF DIRECT-ACTING ANTIVIRALS IN PSYCHIATRIC HEPATITIS C VIRUS INFECTED PATIENTS
    Margusino-Framinan, Luis
    Bobadilla-Perez, Eva
    Carlos Yanez-Rubal, Juan
    Prieto-Perez, Andrea
    Cid-Silva, Purificacion
    Rodriguez-Sotelo, Alejandro
    Gimenez-Arufe, Victor
    Quiroga-Fernandez, Candela
    Isabel Sanclaudio-Luhia, Ana
    Novo-Ponte, Ana
    Mena-De-Cea, Alvaro
    Martin-Herranz, Isabel
    Castro-Iglesias, Angeles
    HEPATOLOGY, 2019, 70 : 966A - 966A
  • [4] Concomitant use of direct-acting antivirals and chemotherapy in hepatitis C virus-infected patients with cancer
    Economides, M. P.
    Mahale, P.
    Kyvernitakis, A.
    Turturro, F.
    Kantarjian, H.
    Naing, A.
    Hosry, J.
    Shigle, T. L.
    Kaseb, A.
    Torres, H. A.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2016, 44 (11-12) : 1235 - 1241
  • [5] Efficacy, Safety, and Predictors of Direct-acting antivirals in Hepatitis C Virus Patients with Heterogeneous Liver Diseases
    De Pace, Vanessa
    Morelli, Maria Cristina
    Ravaioli, Matteo
    Maggi, Fabrizio
    Galli, Silvia
    Vero, Vittoria
    Re, Maria Carla
    Cescon, Matteo
    Pistello, Mauro
    NEW MICROBIOLOGICA, 2019, 42 (04): : 189 - 196
  • [6] Retreatment of Hepatitis C Virus-Infected Patients with Direct-Acting Antiviral Failures
    Pawlotsky, Jean-Michel
    SEMINARS IN LIVER DISEASE, 2019, 39 (03) : 354 - 368
  • [7] Interferon Response in Hepatitis C Virus-Infected Hepatocytes: Issues to Consider in the Era of Direct-Acting Antivirals
    Sung, Pil Soo
    Shin, Eui-Cheol
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (07)
  • [8] The use of all-oral direct-acting antivirals in hepatitis C virus-infected patients with substance use disorders
    Jiang, Xinyi
    Song, Hyun Jin
    Wang, Wei
    Henry, Linda
    Childs-Kean, Lindsey M.
    Lo Re, Vincent, III
    Park, Haesuk
    JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY, 2021, 27 (07): : 873 - 881
  • [9] Generic sofosbuvir-based direct-acting antivirals in hepatitis C virus-infected patients with chronic kidney disease
    Kumar, Manoj
    Nayak, Suman L.
    Gupta, Ekta
    Kataria, Ashish
    Sarin, Shiv K.
    LIVER INTERNATIONAL, 2018, 38 (12) : 2137 - 2148
  • [10] Direct-acting antivirals reduce the risk of non-hepatic cancers among hepatitis C virus-infected patients
    Wang, Wei
    Lo Re, Vincent, III
    Xiao, Hong
    Brown, Joshua
    Guo, Yi
    Park, Haesuk
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2018, 27 : 387 - 388
12345